You are here

Home » Content

STENT TASARIMI, UZUNLUĞU VE ÇAPININ STENT İÇİ RESTENOZ ŞEKİLLERİNE OLAN ETKİSİ

Journal Name:

  • İstanbul Tıp Fakültesi Dergisi

Publication Year:

  • 2003

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
The Relationship Between the patterns of in stent restenosis and stent type, stent diameter and length of the stent. The reasons for differences among locations of the neoinümal proliferative response to implanted stents are unknown. Intrinsic patient related factors and design of the stent seem to be responsible for different patterns of in-stent restenosis (ISR). The angiograp-hic presentation of ISR may provide prognostic information on subsequent target vessel revas-culariz'ation. The aim of this study was to investigate the relationship betwecn the patterns of ISR and stent type, stent diameter and length of the stent. Seventy two ISR patients were İnclu-ded in this study. ISR was angiographically defined as more than 50% narrowing in the stented segment. The patterns of ISR have been categorised as follows: focal (pattern I), diffuse proli-ferative (pattern II) and totai occiusive (pattern III). Two different types of stent were compa-red: Coil (Cook stent) (n= 41) and tubular (NIR stent) (n= 31). Pattern I was found in 37% of patients (n=27), pattern II in 51% (n-37) and pattern III in 11% (n=8). In the coil-stent group, pattern I presented 34% of restenotic lesions, pattern II 56% and pattern III 10%. In the tubu-lar-stem group, pattern I presented 41% of restenotic lesions, pattern II 45% and III 13%. Although coil-stent group tends to be more frequenrly presented with pattern II, this was not statisücally significant. But there was a statistically significant correlation between the diameter and length of the stent and the patterns of ISR (p<0.04, p<0.0l). With decreasing diameter and İncreasing the length of the stent, ISR presented significantly more frequently with pattern II and III. In conelusion, although patterns of ISR do not scem to be influenced by stent design, the diameter and length of the stent is strongly associated with the pattern of ISR.
Bookmark/Search this post with
Abstract (Original Language): 
İmplanle edilmiş stente karşı gelişen neoinümal prolifcrasyonun stent içi lokalizasyonundaki farklılıklara yol açan faktörler net olarak bilinmemektedir. Stent içi restenozunun (SR) farklı patternlerde ortaya çıkmasından sorumlu olan faktörler arasında stente ait özellikler de (stent dizaynı, boyu, çapı) yer alabilir. SR'nun anjiyografik presentasyon şekli sonraki girİşİmsel tedavi yönteminin türü hakkında da yol gösterici olabilir. Bu çalışmanın amacı SR'nun paterni ile stent dizaynı, çapı ve uzunluğu arasındaki ilişkinin araştırılmasıdır. Bu çalışmaya SR olan 72 hasta (72 lezyon) dahil edildi. SR anjiyografik olarak, 6 ay sonra yapılmış olan kontrol anjiyog-rafide stent içerisinde > %50 darlık olması şeklinde tanımlandı. SR paternleri şu şekilde sınıflandırıldı: tip I: "Foka!" SR: stent içi, proksimal veya distal uçta veya eklem bölgesinde ve u¬zunluğu < 10 mm olan restenotik lezyon, tip II: "Diffuz" SR: genellikle tüm stent içi bölgeyi kaplamış veya stent dışı bölgeye uzanmış ve uzunluğu >10 mm olan restenotik lezyon, tip Di : "total oklüzyon": TTMI (liırombolysis in myocardial infaretion) 0 derecede akımı olan lezyon. İki farklı iip stent karşılaştırıldı: Kıvrımlı stent (n=41) ve tubuler stent (n=31). Hastaların %37'sinde (n=27) tip I, %5 l'inde (n=37) ıtp II ve %1 l'inde (n= 8) tip III SR tespit edildi. Kıvrımlı stent grubundaki restenotik lezyonların %34'ünde tip I, %56'sında tip II ve %10'nunda tip III SR saptandı. Tubuler stent grubunda tip I %41 sıklıkla, tip 11 %45 sıklıkla ve tip III SR % 13 sıklıkla tespit edildi. Kıvrımlı stentlerde daha çok diffüz tipte (tip E) SR eğilimi saptanmak İle birlikte bu farklılık istatistİkİ olarak anlamlı bulunmadı (p=0.07). Fakat stent boyu ve çapı ile SR'nun tipi arasındaki ilişkiler anlamlıydı (sırasıyla, p<0.01 ve p<0.04) Stent çapındaki azalma ve boyundaki artış ile birlikte sıklıkla tip II ve tip III SR patentlerine rastlandı. Sonuç olarak, stent içi restenozunun paterni stent dizaynı ile ilişkili değil gibi görünse de stentin çapı ve boyu ile SR'nun paterni arasında anlamlı İlişkiler saptandı. Kullanılan stent çapının azalması ve boyunun artışı ile birlikte sıklıkla diffüz tipte ve total oklüzyon tarzında SR ile karşılaşıldı.
FULL TEXT (PDF): 
PDF icon arastirmax-stent-tasarimi-uzunlugu-capinin-stent-ici-restenoz-sekillerine-olan-etkisi.pdf
  • 3
142-148
  • Turkish

REFERENCES

References: 

1. Barlh KH, Virmani R, Frolİsh J, et al: Paired cornparison of vascular wail reactions to Palınaz Schatz stents, Stıec-ker tantalum stent, and wall stents in canine iiiac and fe-moral arteries. Circulalion; 93:2161 (1996).
2. Baulers C, Banos JL, Van Belle E, McFadden E, Lab-lanche JM, Bertrand M: Stx month angiographic oıılco-me after sııccessfui repeal perculeneous intervenlion for in-sient restenosis. Circulalion; 97:318 (1998).
3. Bautcrs C, Hubert E, Prat A, et al: Pıedictors of restenosis aflcr coronary stent ini plan tation. J. Anı. Coll. Cardi-ol.; 31:1291 (1998).
4. Bonan R, Paimenl P, Scortichini D, el al: Coronary restenosis: evalııation of a restenosis injury index in swine model. AmHeart J; 126:1334 (1993).
Oflaz H., Sezer M., Nişancı Y,, Üngör S., Erdoğan D,, Sağbaş A., Acar R.D., Pamukçu B.,
Erdemsel Y., Püşüroğlu H., Yılmaz E., Erzengin F.
5. Brack MJ, Forbat LN, Skchan JD: Plague herniation thro-ugh a coronary stent. Cathet. Cardiovasc. Diag.; 44:93 (1994).
6. Carrozza J, Kuntz R, Levine M, et al: Angiographic and clinical oulcome of intacoronary stenting: immediate and long term results from large single center experience. J AmCotl Cardiol:23, 1051 (1994).
7. Carter AJ, Laird JR, Kufs WM, et al: Coronary stenting with a novel slainless-steel ballon expandable stents: de-terminants of neointimal fonııation and changes İn arteri-al geometry after placemeııt in an aterosclerotic model. J Am Coll Cardiol; 27:1270 (1996).
8. Dahi J, Radke P, Haager P et al: Clinical and angiographic predictors of recurrent restenosis after percuteneöus transiuminal rotational atherectomy for treatment of dif-fuse in-stent restenosis. Am J Cardio!; 83:862 (1999).
9. Daaerman H, Baim D, Cutlip D, et al: Mechanical debui-king versus balloon angioplasty for the treatment of dif-fuse in-stent restenosis. Am J Cardiol; 82:277 (1999).
10. Dean LS, Holmes DR, Roubin GS, et al: Does stent type determtne clinical outcome? Final results of Gianturco Rubin II randomized trial (abst). Eur Heart J; 19 Suppl: 47(1998).
11. Dussaillant GR, Mintz GS, Pichard AD: Small stent size and intimal hyperplasia contribtıte to restenosis. A volu-metric intravascular ultrasound analysis. J Am Coll. Cardiol.; 26:720 (1995).
12. Edelman ER, Rogers C: Pathobiological responses to stenting. Am J Cardiot;81 Suppl 7A:4-6E (1998).
13. Elizaga J, Botas J, Garcia EJ: Intracoranary ultrasound reslts of slotted tube and coilstents after high pressure sient deployment guided by angiography. (Abstr) Circ.:96 (suppl):233. (1997).
14. Elıchaninoff H, Koning R, Tron C, Gupta V, Cribicr A: Balloon angioplasty for the treatment of coronary in-slent restenosis: immediate results and 6 montn angiographic recurrent restenosis rate. J Am Coll Cardiol;32:980 (1998).
15. Escaned J, Goicola J, Alfonso F: Influence of stent design on the relationship betwccn acute gam and Iate lumi-nal loss. J. Am. Coll. Cardioi.;31 (Supp A) 415 A (1998).
16. Fischman DL, Leon MB, Baim DS et al: for the Stent restenosis Study investigators. A randomized cornparison of coronary stent placement and balloon angioplasty in the treatment of coronary arlery disease. N Eng J Med; 331:496 (1994).
17. Hoffman R, Keers B, Oljaca B: Predictors of diffuse in-atent restenosis (abstract) Circulalion.;96:I-472-II-473 (1997).
18. Hoffmann R, Mintz GS, Dussaillant GR, Pompa Jj, Pic-lıard AD, Satler LS, Kent KM, et ai: Patterns and meeha-nism of in-stent restenosis; serial intravascular ultrasound study. Ciculation.; 94: 1247(1996).
19. Ikara Y, Haro K, Tamura T, Sachi F, Yamaguchi T: Lu-minal loss and site of restenosis after Palmaz Schatz coronary stent implantation. J. Am. Coll. Cardiol. 1995;76:117-120
20. Kastrati A, Schömig A, Elezi S, et al: Predictivc factors of restenosis after coronary stent placement. j Am Colİ Cardiol.; 30:1428 (1997).
21. Kimura T, Tamuri T, Yokoi H, Nobuyushi M: Long-term clinical and angiographic follow-up after placement of Palmaz-Schatz coronary stent. J. Interv Curdioi;7:129 (1994).
22. Kini A, Marmur JD, Dangas G, Choudhary S, Sharma SK: Angiographic patterns of in-stent restenosis and implications on subsequent revascularization. Cat-het.Cardiovasc. lntervent., 49:23 (2000).
23. Kornowski R, Biıargava B, Fuchs S, Lansky AJ, Satler LF, et al: Procedural results and Iate clinical outeomes after percutaneous interventions using long (>25 mm) versus short (<20 mm) stents. J Am Cotl Cardiol.;35: 612 (2000).
24. Kornowski R, Mintz G, Kent K, et al: Increased restenosis in diabetes melütus after coronary interventions due to exaggerated intimal hyperplasia. Circulation; 95:1366 (1997).
25. Mehran R, Abizaid A, Mintz G, et al: Patterns of İn-stent restenosis: elassification and impact on subsequent target lesion revascularization. J Am Coll Cardiol;31 (Suppl A):I41A(1998).
26. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB: Angiographic patterns of in-stent restenosis. Circu-Iation.;100:1872(1999).
27. Mehran R, Mintz G, Satler L, et al: Treatment of in stent restenosis with excimer laser coronary angioplasty: mec-hanism and results compared with PTCA alone. Circulalion; 96:2183(1997).
28. Mintz GS, Hoffman R, Mehran R, et al: İn-stent restenosis: The Washington Hospital Service experience. AM J Cardiol; 81 Suppl 7A:7-Î3E (1998).
29. Reimers B, Mousa 1, Akiyama T, Tucci G, Fcrrano M, Martini G, Blengio S, Di Mario C, Colombo A: Long term clinical follo\v-up after succesful repeat percuteno-us intervention for slent restenosis. J. Am Coll Cardiol,; 30:186(1997).
30. Rogers C, Edelman ER, Endovascular stent designs dic-tates experimental restenosis and thrombosis. Circulation.; 91: 2955 (1995).
31. Sawade Y, Nosaka H, Kimura T, Nobuyoshİ M: Inilial and six months outcome of Palmaz-Schatz stent implantation: stress/benestent equivalent vs. nonequivalent lesions. J Am Coll Cardiol; 27{Suppl A):252 (1997).
32. Schwart2 RS, Huber KC, Murphy JG, et al: Restenosis and the proportional neointimal Tesponse to coronary ar-tery injury: results in a porehine model. J Am Coll Cardiol; 19:1493 (1992).
33. Serruys PW, de Jaegeıe P, Kiemcneij F, Maçaya C, Rutsch W, Heyndricks G, Emanuelson H, et ai: A cornparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group, N. Engl. J. Med.;33I: 489 (1994).
34. Serruys PW, van Hout B, Bonnİer H et al: for the Benestent Study Group. Randomized cornparison of implantation of heparin coated stents with ballon angioplasty in seleeted patients with coronary artery disease. (Benestent II) Lancct; 352:673 (1998).
35. Serruys S, Emanuelsen H, van der Giessen W, et aî: Heparin coated Palmaz Shatz stents in human coronary arteries: early outcome of the Benestent II pilot study. Circulation; 93:412 (1996).
36. Sharma JK, Kini T, Dangas G, Cocke TP: Randomized trial of rotational atherectomy vs. balloon angioplasty for in-stent restenosis (ROSTER); interim analysis of 150 cases. Eur Heart J.;20:24a (1999).
37. Sharma S, Duvvuri S, Dangas G, Kini A, et al: Rotational atherectomy for in-stent restenosis: acute and long
Stent Tasarımı, Uzunluğu ve Çapının Stent İçi Restenoz Şekillerine Olan Etkisi
term results of first 100 cases. J Am Col! Cardiol; 32:1358 (1998).
38. Sharma S, Rajawat Y, Kakaraia V, Marmur J, Duvvuri S, Cocke T, Ambrose J: Angiographic pattern of in-stent restenosis after palmaz-schalz stent implantation. J Am Coll Cardiol; 27(Suppl A):313A. (1997).
39. Sousa JE, Costa MA, Abizaid A, Abizaid AS, Feres F, Pİnto IMF, Seixas AC, ct al: Lack of neointimal prolife-ration after implantation of siralıınıus coated stent in hu-man coronary arteries. Circulation.; 103:192 (2001).
40. Tamtgana R, Harachi H, Emoto H, Kombic H, Holhnan J: Effect of stent design and serum cholesterol level on the restenosis rate in atherosclerotic rabbits. Am. Heart J.; 126:1049(1993).
41. Tierstein P, Massulo U, Jani S, et al: Catheter based radi-otherapy to inhibit restenosis after coronary stenting. N Engl J Med.; 336:1697 (1997).
42. Verin V, Popowski Y, De Bruyne B, Baumgart D, Saııer-wein W, Lins M et al: Endoiuminal beta-radiation the-rapy for the prevention of coronary restenosis after balloon angioplasty. N Eng J Med.; 344: 243 (2001).
43. Yokoi H, Kimura T, Nakagavva Y, Nosaka H, Nobuyoshi M: Long term clinical and quantitative angiographic fol-low-up after Palmaz-Schatz stent restenosis. J Am Coll Cardiol; 27 (Suppl A): 224 A (1996).

Thank you for copying data from http://www.arastirmax.com